Skip to main content
Erschienen in: International Cancer Conference Journal 1/2016

01.01.2016 | Case report

A case of uterine corpus large cell neuroendocrine carcinoma showing prominent myometrial invasion without any macroscopically clear tumor formation

verfasst von: Haruhisa Konishi, Kazuhiro Takehara, Yoshifumi Sugawara, Norihiro Teramoto, Yasuko Yamamoto, Shinichi Okame, Yuko Shiroyama, Takashi Yokoyama, Takayoshi Nogawa

Erschienen in: International Cancer Conference Journal | Ausgabe 1/2016

Einloggen, um Zugang zu erhalten

Abstract

Large cell neuroendocrine carcinoma (LCNEC) arising in the uterine corpus is a very rare. Here, we report our experience with a primary LCNEC in the uterine corpus that showed prominent myometrial invasion without exhibiting any macroscopically distinct tumor formation in the uterine cavity. The patient was a 54-year-old woman. She had a past medical history of right breast cancer and was referred to our department with irregular genital bleeding, elevated serum carcinoembryonic antigen in periodic medical examinations and computed tomography (CT) findings of uterine cavity dilation. Endometrial biopsy suggested a poorly differentiated tumor. Although magnetic resonance imaging (MRI) showed hematometra-like findings in the uterine cavity, it did not indicate any clear endometrial lesion. The myometrium was unequally thickened, and the entire muscle layer showed a high signal intensity on diffusion-weighted images. Fluorine-18-deoxyglucose positron emission tomography/computed tomography (FDG-PET/CT) showed strong FDG accumulation in the whole uterus, and on the bottom of the uterus, there was a ring-shaped accumulation mainly in the muscle layer. The postoperative resected specimen did not show any tumor formation in the uterine cavity, whereas the myometrium was hard and thickened, and colored white overall. Histopathological examination revealed prominent myometrial invasion in most layers, cervical stromal invasion and pelvic lymph node metastasis. The diagnosis was a LCNEC of the uterine corpus, at FIGO stage IIIC1 and pT2N1M0. With these patients, we found that functional metabolic images, such as MRI diffusion-weighted images and FDG-PET/CT, were useful in identifying the lesion. Preoperatively, when a poorly differentiated tumor is estimated and characteristic myometrial invasion is suspected, the possibility of LCNEC should be considered.
Literatur
1.
Zurück zum Zitat Asamura H, Kameya T, Matsuno Y et al (2006) Neuroendocrine neoplasms of the lung: a prognostic spectrum. J Clin Oncol 24:70–76CrossRefPubMed Asamura H, Kameya T, Matsuno Y et al (2006) Neuroendocrine neoplasms of the lung: a prognostic spectrum. J Clin Oncol 24:70–76CrossRefPubMed
2.
Zurück zum Zitat Erhan Y, Dikmen Y, Yucebilgin MS et al (2004) Large cell neuroendocrine carcinoma of the uterine corpus metastatic to brain and lung: case report and review of the literature. Eur J Gynaecol Oncol 25:109–112PubMed Erhan Y, Dikmen Y, Yucebilgin MS et al (2004) Large cell neuroendocrine carcinoma of the uterine corpus metastatic to brain and lung: case report and review of the literature. Eur J Gynaecol Oncol 25:109–112PubMed
3.
Zurück zum Zitat Mulvany NJ, Allen DG (2008) Combined large cell neuroendocrine and endometrioid carcinoma of the endometrium. Int J Gynecol Pathol 27:49–57CrossRefPubMed Mulvany NJ, Allen DG (2008) Combined large cell neuroendocrine and endometrioid carcinoma of the endometrium. Int J Gynecol Pathol 27:49–57CrossRefPubMed
4.
Zurück zum Zitat Albores-Saavedra J, Martinez-Benitez B, Luevano E (2008) Small cell carcinomas and large cell neuroendocrine carcinomas of the endometrium and cervix: polypoid tumors and those arising in polyps may have a favorable prognosis. Int J Gynecol Pathol 27:333–339CrossRefPubMed Albores-Saavedra J, Martinez-Benitez B, Luevano E (2008) Small cell carcinomas and large cell neuroendocrine carcinomas of the endometrium and cervix: polypoid tumors and those arising in polyps may have a favorable prognosis. Int J Gynecol Pathol 27:333–339CrossRefPubMed
5.
Zurück zum Zitat Terada T (2010) Large cell neuroendocrine carcinoma with sarcomatous changes of the endometrium: a case report with immunohistochemical studies and molecular genetic study of KIT and PDGFRA. Pathol Res Pract 206:420–425CrossRefPubMed Terada T (2010) Large cell neuroendocrine carcinoma with sarcomatous changes of the endometrium: a case report with immunohistochemical studies and molecular genetic study of KIT and PDGFRA. Pathol Res Pract 206:420–425CrossRefPubMed
6.
Zurück zum Zitat Deodhar KK, Kerkar RA, Suryawanshi P et al (2011) Large cell neuroendocrine carcinoma of the endometrium: an extremely uncommon diagnosis, but worth the efforts. J Cancer Res Ther 7:211–213CrossRefPubMed Deodhar KK, Kerkar RA, Suryawanshi P et al (2011) Large cell neuroendocrine carcinoma of the endometrium: an extremely uncommon diagnosis, but worth the efforts. J Cancer Res Ther 7:211–213CrossRefPubMed
7.
Zurück zum Zitat Shahabi S, Pellicciotta I, Hou J et al (2011) Clinical utility of chromogranin A and octreotide in large cell neuro endocrine carcinoma of the uterine corpus. Rare Tumors 3:e41PubMedCentralCrossRefPubMed Shahabi S, Pellicciotta I, Hou J et al (2011) Clinical utility of chromogranin A and octreotide in large cell neuro endocrine carcinoma of the uterine corpus. Rare Tumors 3:e41PubMedCentralCrossRefPubMed
8.
Zurück zum Zitat Makihara N, Maeda T, Nishimura M et al (2012) Large cell neuroendocrine carcinoma originating from the uterine endometrium: a report on magnetic resonance features of 2 cases with very rare and aggressive tumor. Rare Tumors 4:e37PubMedCentralCrossRefPubMed Makihara N, Maeda T, Nishimura M et al (2012) Large cell neuroendocrine carcinoma originating from the uterine endometrium: a report on magnetic resonance features of 2 cases with very rare and aggressive tumor. Rare Tumors 4:e37PubMedCentralCrossRefPubMed
9.
Zurück zum Zitat Nguyen ML, Han L, Minors AM et al (2013) Rare large cell neuroendocrine tumor of the endometrium: a case report and review of the literature. Int J Surg Case Rep 4:651–655PubMedCentralCrossRefPubMed Nguyen ML, Han L, Minors AM et al (2013) Rare large cell neuroendocrine tumor of the endometrium: a case report and review of the literature. Int J Surg Case Rep 4:651–655PubMedCentralCrossRefPubMed
10.
Zurück zum Zitat Tanimoto H, Hamasaki A, Akimoto Y et al (2012) A case of large cell neuroendocrine carcinoma (LCNEC) of the uterine cervix successfully treated by postoperative CPT-11 + CDDP chemotherapy after non-curative surgery. Gan To Kagaku Ryoho 39:1439–1441 (in Japanese)PubMed Tanimoto H, Hamasaki A, Akimoto Y et al (2012) A case of large cell neuroendocrine carcinoma (LCNEC) of the uterine cervix successfully treated by postoperative CPT-11 + CDDP chemotherapy after non-curative surgery. Gan To Kagaku Ryoho 39:1439–1441 (in Japanese)PubMed
11.
Zurück zum Zitat Miyasaka N, Kubota T (2011) Unusually intense 18F-fluorodeoxyglucose (FDG) uptake by a mature ovarian teratoma: a pitfall of FDG positron emission tomography. J Obstet Gynaecol Res 37:623–628CrossRefPubMed Miyasaka N, Kubota T (2011) Unusually intense 18F-fluorodeoxyglucose (FDG) uptake by a mature ovarian teratoma: a pitfall of FDG positron emission tomography. J Obstet Gynaecol Res 37:623–628CrossRefPubMed
12.
Zurück zum Zitat Nishijima N, Kajihara M (2014) A case of mature cystic teratoma presenting intense FDG uptake. Jpn J Clin Radiol 59:1769–1773 Nishijima N, Kajihara M (2014) A case of mature cystic teratoma presenting intense FDG uptake. Jpn J Clin Radiol 59:1769–1773
Metadaten
Titel
A case of uterine corpus large cell neuroendocrine carcinoma showing prominent myometrial invasion without any macroscopically clear tumor formation
verfasst von
Haruhisa Konishi
Kazuhiro Takehara
Yoshifumi Sugawara
Norihiro Teramoto
Yasuko Yamamoto
Shinichi Okame
Yuko Shiroyama
Takashi Yokoyama
Takayoshi Nogawa
Publikationsdatum
01.01.2016
Verlag
Springer Japan
Erschienen in
International Cancer Conference Journal / Ausgabe 1/2016
Elektronische ISSN: 2192-3183
DOI
https://doi.org/10.1007/s13691-015-0217-7

Weitere Artikel der Ausgabe 1/2016

International Cancer Conference Journal 1/2016 Zur Ausgabe

Bei seelischem Stress sind Checkpoint-Hemmer weniger wirksam

03.06.2024 NSCLC Nachrichten

Wie stark Menschen mit fortgeschrittenem NSCLC von einer Therapie mit Immun-Checkpoint-Hemmern profitieren, hängt offenbar auch davon ab, wie sehr die Diagnose ihre psychische Verfassung erschüttert

Antikörper mobilisiert Neutrophile gegen Krebs

03.06.2024 Onkologische Immuntherapie Nachrichten

Ein bispezifischer Antikörper formiert gezielt eine Armee neutrophiler Granulozyten gegen Krebszellen. An den Antikörper gekoppeltes TNF-alpha soll die Zellen zudem tief in solide Tumoren hineinführen.

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

15% bedauern gewählte Blasenkrebs-Therapie

29.05.2024 Urothelkarzinom Nachrichten

Ob Patienten und Patientinnen mit neu diagnostiziertem Blasenkrebs ein Jahr später Bedauern über die Therapieentscheidung empfinden, wird einer Studie aus England zufolge von der Radikalität und dem Erfolg des Eingriffs beeinflusst.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.